With factors like escalating tensions and many nations facing unprecedented debt crises, the concept of financial sovereignty ...

The US Food and Drug Administration (FDA) has approved Enflonsia (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates (newborns) and ...

Cunard has come together with Abbey Road Studios to bring a new and exclusive Listening Lounge experience to music lovers on board Queen Elizabeth. The luxury cruise line has partnered with the iconic ...

The US is at war. It has always been at war. Whether a world war, a proxy conflict, an armed intervention, a psyop, or a ...

Greggs shares have fallen heavily since the tail end of 2024. Does this make the FTSE 250 share a brilliant dip buy for patient investors? The post Here’s the growth forecast for Greggs shares up to ...

London’s junior stock market celebrates its 30th birthday with listings at a two-decade low — now might be the right time to buy ...

Harvey Jones made a bet on the struggling BP share price. So far, it's been a bad one. Yet analysts appear to be forecasting ...

There are many stories about the birth of FD Technologies, the company formerly known as First Derivatives, but one of them ...

Traders are shifting their focus in the crypto world,while XRP and Cardano have long been popular new projects like Remittix (RTX) are attracting huge institutional attention. Analysts predict RTX ...

Alibaba's QwenLong-L1 helps LLMs deeply understand long documents, unlocking advanced reasoning for practical enterprise applications.

Paul Summers ponders whether he should welcome two great FTSE companies that served him well back into his portfolio. What could possibly go wrong? The post 2 brilliant FTSE growth stocks I’m ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...